Department of Intensive Care Medicine, Satakunta Central Hospital, Pori, Finland.
Anaesthesiology and Intensive Care, Department of Surgical Sciences, Uppsala University Hospital, Uppsala, Sweden.
Acta Anaesthesiol Scand. 2020 Sep;64(8):1144-1153. doi: 10.1111/aas.13612. Epub 2020 Jun 1.
Few studies have examined survival in intensive care unit (ICU) patients after the restriction of life-sustaining treatment (LST). We aimed to analyse independent factors associated with hospital and 12-month survival rates in ICU patients after treatment restrictions.
This retrospective observational study examined all patients treated in adult ICUs from 1 January 2016 until 31 December 2016 included in the Finnish ICU Registry. Multivariable logistic regression analysis was performed to explain the effect on survival.
Decisions to limit LST were made for 2444 patients (13.7%; 95% CI 13.2-14.2). ICU, hospital, and 12-month survival rates were 71% (95% CI 69-73), 49% (95% CI 47-51), and 24% (95% CI 22-26), respectively. In patients for whom life support was withheld, increased 12-month survival rates were associated with admission from the operating theatre (OR 1.9, 95% CI 1.1-3.4), good pre-hospital physical fitness (OR 4.7, 95% Cl 1.2-16.8) and being housed at home (OR 2.0, 95% Cl 1.4-2.8). Decreased survival rates were associated with admission from a hospital ward (OR 0.67, 95% Cl 0.5-0.9), higher comorbidity (OR 0.6, 95% Cl 0.4-0.9), cancer (OR 0.4, 95%CI 0.2-0.9), greater illness severity (SAPS II; OR 0.98, 95% Cl 0.98-0.99), and higher care intensity (TISS-76; OR 0.93, 95% Cl 0.92-0.95).
Survival among ICU patients with limited treatment was higher than expected. Advanced age was not associated with higher mortality, potentially because treatment restrictions may be set more easily for older patients.
很少有研究探讨限制生命支持治疗(LST)后重症监护病房(ICU)患者的生存情况。我们旨在分析 ICU 患者在限制治疗后与医院和 12 个月生存率相关的独立因素。
本回顾性观察性研究纳入了 2016 年 1 月 1 日至 2016 年 12 月 31 日期间在芬兰 ICU 注册中心接受治疗的所有成年 ICU 患者。采用多变量逻辑回归分析解释对生存的影响。
共有 2444 例患者(13.7%;95%CI 13.2-14.2)做出限制 LST 的决定。ICU、医院和 12 个月生存率分别为 71%(95%CI 69-73)、49%(95%CI 47-51)和 24%(95%CI 22-26)。在未接受生命支持的患者中,12 个月生存率提高与以下因素相关:从手术室入院(OR 1.9,95%CI 1.1-3.4)、良好的院前体能(OR 4.7,95%CI 1.2-16.8)和居家安置(OR 2.0,95%CI 1.4-2.8)。较低的生存率与从医院病房入院(OR 0.67,95%CI 0.5-0.9)、更高的合并症(OR 0.6,95%CI 0.4-0.9)、癌症(OR 0.4,95%CI 0.2-0.9)、更高的疾病严重程度(SAPS II;OR 0.98,95%CI 0.98-0.99)和更高的护理强度(TISS-76;OR 0.93,95%CI 0.92-0.95)相关。
接受限制治疗的 ICU 患者的生存率高于预期。年龄较大与死亡率增加无关,这可能是因为对老年患者更容易设定治疗限制。